Pharma Reviews: Sluggish Exports To Cap Pharma Revenue Growth At 9%: CRISIL - Moneylife

Revenue growth of the Indian pharmaceutical sector will moderate to 9% this fiscal, compared with a healthy 12.5% in the past fiscal.
Read more: Sluggish Exports To Cap Pharma Revenue Growth At 9%: CRISIL - Moneylife